Johnson & Johnson neemt sectorgenoot Intra-Cellular Therapies over voor omgerekend 14,6 miljard dollar. Dit werd maandag ...
Johnson and Johnson revealed lower earnings and sales numbers than expected in Q4 2022 Even before Q4 numbers were released, JNJ started falling after a slew of new stories hit the press Even ...